Skip to main content
Clinical Trials/CTRI/2024/07/069736
CTRI/2024/07/069736
Not yet recruiting
Phase 4

Comparison between ultrasound-guided injection of triamcinolone in sacroiliac joints and oral Etoricoxib in patients with axial spondyloarthritis: a randomized controlled trial - NI

INSTITUTE OF NEUROSCIENCES KOLKATA0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: M458- Ankylosing spondylitis sacral andsacrococcygeal regionHealth Condition 2: M458- Ankylosing spondylitis sacral andsacrococcygeal region
Sponsor
INSTITUTE OF NEUROSCIENCES KOLKATA
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • i.Patients \= 18 years of age
  • ii.Fulfilling the ASAS classification criteria of Axial Spondyloarthritis 2011\.
  • iii.Active disease defined by Bath ankylosing spondylitis disease activity index (BASDAI) score \= 4, or ASDAS \= 2\.1\.

Exclusion Criteria

  • 1\.Bony ankylosis of sacroiliac joint \- Grade 4 sacroilitis according to the modified New York criteria
  • 2\.Patients with only peripheral spondyloarthropathy
  • 3\.Predominantly Psoriatic arthritis
  • 4\.Predominantly Enteropathic arthritis
  • 5\.Patients on biologics and JAK inhibitors
  • 6\. Allergy to etoricoxib
  • 7\. Contraindication to NSAIDs
  • 8\. Pregnancy or lactation at the time of study entry
  • 8\. Infective sacroiliitis
  • 10\. History of corticosteroid injection in the sacroiliac joint within six months before study entry

Outcomes

Primary Outcomes

Not specified

Similar Trials